Related Experiment Video
Updated: Nov 7, 2025

Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
Lactobacillus reuteri Colonisation of Extremely Preterm Infants in a Randomised Placebo-Controlled Trial
Johanne E Spreckels1,2, Erik Wejryd1, Giovanna Marchini3
1Department of Biomedical and Clinical Sciences, Linköping University, SE-581 83 Linköping, Sweden.
Insights
Probiotic Lactobacillus reuteri DSM 17938 successfully colonizes extremely low birth weight (ELBW) infants. This colonization, along with female sex, improved head growth in ELBW infants during the neonatal period.
Area of Science:
- Neonatology
- Microbiome research
- Probiotics
Background:
- Lactobacillus reuteri DSM 17938 reduces morbidities in very low birth weight infants, but its effect on extremely low birth weight (ELBW) infants is unclear.
- Previous trials showed improved head growth but not feeding tolerance or morbidities in preterm ELBW infants supplemented with L. reuteri.
- Colonization by L. reuteri DSM 17938 in preterm ELBW infants requires further investigation.
Purpose of the Study:
- To investigate the colonization of preterm ELBW infants with Lactobacillus reuteri DSM 17938.
- To assess the impact of L. reuteri colonization on infant growth and feeding parameters.
- To explore correlations between maternal milk composition, L. reuteri abundance, and infant outcomes.
Main Methods:
- A randomized placebo-controlled trial involving 132 preterm ELBW infants.
- Quantitative PCR analysis of 582 fecal DNA samples to determine L. reuteri colonization.
- Measurement of human milk oligosaccharides in maternal milk samples.
Main Results:
- Successful colonization with L. reuteri DSM 17938 was achieved in at least 86% of supplemented ELBW infants.
- Colonization occurred despite prematurity, antibiotic use, and feeding methods.
- Higher L. reuteri abundance correlated with faster achievement of full enteral feeding.
- Female sex and L. reuteri colonization improved head growth from birth to four weeks.
Conclusions:
- Lactobacillus reuteri DSM 17938 supplementation leads to successful and sustained colonization in extremely low birth weight infants.
- L. reuteri colonization may positively influence head growth and feeding advancement in this vulnerable population.
- Further research can explore optimizing probiotic strategies for ELBW infants based on colonization success and maternal milk factors.
Abstract:
Lactobacillus reuteri DSM 17938 supplementation reduces morbidities in very low birth weight infants (<1500 g), while the effect on extremely low birth weight infants (ELBW, <1000 g) is still questioned. In a randomised placebo-controlled trial (ClinicalTrials.gov ID NCT01603368), head growth, but not feeding tolerance or morbidities, improved in L. reuteri-supplemented preterm ELBW infants. Here, we investigate colonisation with the probiotic strain in preterm ELBW infants who received L. reuteri DSM 17938 or a placebo from birth to postmenstrual week (PMW) 36. Quantitative PCR was used on 582 faecal DNA samples collected from 132 ELBW infants at one, two, three, and four weeks, at PMW 36, and at two years of age. Human milk oligosaccharides were measured in 31 milk samples at two weeks postpartum. At least 86% of the ELBW infants in the L. reuteri group were colonised with the probiotic strain during the neonatal period, despite low gestational age, high antibiotic pressure, and independent of infant feeding mode. Higher concentrations of lacto-N-tetraose, sialyl-lacto-N-neotetraose c, and 6'-sialyllactose in mother's milk weakly correlated with lower L. reuteri abundance. Within the L. reuteri group, higher L. reuteri abundance weakly correlated with a shorter time to reach full enteral feeding. Female sex and L. reuteri colonisation improved head growth from birth to four weeks of age. In conclusion, L. reuteri DSM 17938 supplementation leads to successful colonisation in ELBW infants.
More Related Videos
11:04Author Spotlight: Methods for Electroporation and Transformation Confirmation in Limosilactobacillus reuteri DSM20016
Published on: June 23, 2023
09:36Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
Published on: July 28, 2022